This week in gene and cell therapy - 28 June 2019

Gene and cell therapy headlines 24 June - 28 June

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

Hematopoietic stem cell-targeted neonatal gene therapy with a clinically applicable lentiviral vector corrects osteopetrosis in oc/oc mice

The Convergence of Stem Cell Technologies and Phenotypic Drug Discovery

FDA Grants Fast Track Designation for Torque’s First Deep-Primed T Cell Cancer Immunotherapy Program, TRQ-1501

Daratumumab-Based Regimens Are Highly Effective And Well Tolerated In Relapsed Or Refractory Multiple Myeloma Regardless Of Patient Age: Subgroup Analysis Of The Phase 3 CASTOR And POLLUX Studies